Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas
14 ビュー
• 07/18/23
0
0
埋め込む
administrator
加入者
Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント